Skip to content

Celularity Inc

CELU

Latest QuantConomy context for CELU: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class
stock
Primary venue
NASDAQ
Recent signals
3
SEC filings
20
Asset profile

Celularity Inc

QuantConomy has a structured record for CELU. More descriptive asset metadata will appear here when the platform record includes it.

Symbol
CELU
Name
Celularity Inc
Coverage
3 market/data records
Sources
alpaca fmp alphavantage sec nasdaq
Latest signal rows

Recent signals for CELU

Scored rows are pulled from the same signal API used by the digests.

Signal Direction Score Observed Reason
executive change
neutral
75
Jun 25, 10:15 PM CELU filed 8-K: Director or Officer Changes - 1 material event - [strong neutral signal]
passive decrease
neutral
53
Jun 24, 02:15 AM PHILIP & DANIELE BARACH FAMILY TRUST decreased passive stake in CELU from 20.10% to 15.80% - (13G - passive investment) - 5,514,686 shares - [moderate neutral signal]
delisting
very bearish
75
Jun 12, 10:00 PM CELU filed 8-K: Delisting Notice - 1 material event - [strong very bearish signal]

OWNERSHIP signals are experimental: historical 13D/G coverage is still being backfilled, so results may be sparse or empty.

Market coverage

Market Exchange Source Asset record
CELU NASDAQ alpaca Celularity Inc. Class A Common Stock
CELU NASDAQ fmp Celularity Inc.
CELU NASDAQ alphavantage Celularity Inc - Class A

Recent insider transactions

Buys, last 90d
0
Sells, last 90d
0
Rows
20
Date Insider Role Type Shares Price Value Filing
Jun 19, 2026 Barach Daniele Wolf Insider other 1,204,819 4 on EDGAR
Jun 19, 2026 Philip & Daniele Barach Family Trust Insider other 1,204,819 4 on EDGAR
Jun 19, 2026 Barach Philip Alan Insider other 1,204,819 4 on EDGAR
Apr 13, 2026 Hariri Robert J Chief Executive Officer exercise 3,281 $0.00 $0 4 on EDGAR
Apr 13, 2026 Brigido Stephen Pres., Functional Regeneration exercise 821 $0.00 $0 4 on EDGAR
Apr 13, 2026 Haines John R Senior Exec Vice President exercise 1,641 $0.00 $0 4 on EDGAR
Jan 12, 2026 LeVien Vincent Insider grant 28,847 $0.00 $0 4 on EDGAR
Jan 12, 2026 Diamandis Peter Insider grant 20,385 $0.00 $0 4 on EDGAR
Jan 12, 2026 Parks Diane L. Insider grant 30,000 $0.00 $0 4 on EDGAR
Jan 12, 2026 Parks Diane L. Insider grant 30,000 $0.00 $0 4 on EDGAR
Jan 12, 2026 Ling Geoffrey M.D. Insider grant 19,231 $0.00 $0 4 on EDGAR
Jan 12, 2026 Ling Geoffrey M.D. Insider grant 19,231 $0.00 $0 4 on EDGAR
Jan 12, 2026 LeVien Vincent Insider grant 28,847 $0.00 $0 4 on EDGAR
Jan 12, 2026 Diamandis Peter Insider grant 20,385 $0.00 $0 4 on EDGAR
Dec 29, 2025 LeVien Vincent Insider grant 125,000 $0.00 $0 4 on EDGAR
Dec 29, 2025 Parks Diane L. Insider grant 125,000 $0.00 $0 4 on EDGAR
Dec 29, 2025 Diamandis Peter Insider grant 125,000 $0.00 $0 4 on EDGAR
Dec 29, 2025 Ling Geoffrey M.D. Insider grant 125,000 $0.00 $0 4 on EDGAR
Dec 19, 2025 Diamandis Peter Insider grant 67,416 $0.00 $0 4 on EDGAR
Dec 19, 2025 Ling Geoffrey M.D. Insider grant 67,416 $0.00 $0 4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

Query CELU context like a database.

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.

No spam, no noise. Just the launch and the occasional preview.

More: All insider trades · How to read a Form 4 · API access